Wordt geladen...
Development of a Malignancy-Associated Proteomic Signature for Diffuse Large B-Cell Lymphoma
The extreme pathological diversity of non-Hodgkin’s lymphomas has made their accurate histological assessment difficult. New diagnostics and treatment modalities are urgently needed for these lymphomas, particularly in drug development for cancer-specific targets. Previously, we showed that a subset...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Investigative Pathology
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2708791/ https://ncbi.nlm.nih.gov/pubmed/19498000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2009.080707 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|